Paul A Friedman is of Prelude Therapeutics Inc. Currently has a direct ownership of 500,098 shares of PRLD, which is worth approximately $1.39 Million. The most recent transaction as insider was on Sep 29, 2020, when has been sold 448,370 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 500K
0% 3M change
0% 12M change
Total Value Held $1.39 Million

PAUL A FRIEDMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2020
BUY
Conversion of derivative security
-
448,370 Added 47.27%
500,098 Common Stock

Also insider at

MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
ALXN
ALEXION PHARMACEUTICALS, INC.
PAF

Paul A Friedman

West Conshohocken, PA

Track Institutional and Insider Activities on PRLD

Follow Prelude Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRLD shares.

Notify only if

Insider Trading

Get notified when an Prelude Therapeutics Inc insider buys or sells PRLD shares.

Notify only if

News

Receive news related to Prelude Therapeutics Inc

Track Activities on PRLD